Deoxycholic Acid Activates β-Catenin Signaling Pathway and Increases Colon Cell Cancer Growth and Invasiveness

Molecular Biology of the Cell

Volumn 15, Issue 5, 2004, Pages 2156-2163

  Pai, Rama ^a   Tarnawski, Andrzej S ^a   Tran, Teresa ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CYCLIN D1; DEOXYCHOLIC ACID; SMALL INTERFERING RNA; UROKINASE; UVOMORULIN;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; EVIDENCE BASED MEDICINE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION;

BETA CATENIN; BIOLOGICAL ASSAY; CADHERINS; CELL LINE; COLONIC NEOPLASMS; CYCLIN D1; CYTOSKELETAL PROTEINS; DEOXYCHOLIC ACID; GENE EXPRESSION REGULATION; HUMANS; NEOPLASM INVASIVENESS; PHOSPHORYLATION; RECEPTORS, CELL SURFACE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TYROSINE; URINARY PLASMINOGEN ACTIVATOR;

EID: 2342475205     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E03-12-0894     Document Type: Article

References (45)

1. Alexander, N., Wong, C., and Pignatelli, M. (2002). β-Catenin - a linchpin in colorectal carcinogenesis? Am. J. Pathol. 160, 389-401.
2. Andreasen, P.A., Kjoller, L., Christensen, L., and Duffy, M.J. (1997). The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72, 1-22.
3. Andrews, N.C., and Faller, D.V. (1991). A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acid Res. 19, 2499.
4. Arber, N., Doki, Y., Han, E.K.-H., Sgambato, A., Zhou, P., Kim, N.-H., Delohery, T., Klein, M.G., Holt, P.R., and Weinstein, I.B. (1997). Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res. 57, 1569-1574.
5. Arber, N., Hibshoosh, H., Moss, S.F., Sutter, T., Zhang, Y., Begg, M., Wang, S., Weinstein, I.B., and Holt, P.R. (1996). Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis. Gastroenterology 110, 669-674.
6. Armstrong, B., and Doll, R. (1975). Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int. J. Cancer 5, 617-631.
7. Bartkova, J., Lukas, J., Struss, M., and Bartek. (1994). The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas. Int. J. Cancer 58, 568-573.
8. Bayerdorffer, E., Mannes, G.A., Ochsenkuhn, T., Dirschedl, P., Wiebecke, B., and Paumgartner, G. (1995). Unconjugated secondary bile acids in the serum of patients with colorectal adenomas. Gut 36, 268-273.
9. Ben-Ze'v, A., and Geiger, B. (1998). Differential molecular interactions of beta-catenin and plakoglobin in adhesion, signaling and cancer. Curr. Opin. Cell Biol. 10, 629-639.
10. Brabletz, T., Jung, A., Reu, S., Porzner, M., Hlubek, F., Kunz-Schughart, L.A., Knuechel, R., and Kirchner, T. (2001). Variable β-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl. Acad. Sci. USA 98, 10356-10361.
11. Breuer, N., and Goebell, H. (1985). The role of bile acids in colonic carcinogenesis. Klin. Wochenschr. 63, 97-105.
12. Cohen, B.I., and Raicht, R.F. (1981). Effects of bile acids on colon carcinogenesis in rats treated with carcinogens. Cancer Res. 41, 3759-3760.
13. Comoglio, P.M., and Trusolino, L. (2002). Series introduction: invasive growth: from development to metastasis. J. Clin. Investig. 109, 857-862.
14. Debruyne, P.R., Bruyneel, E.A., Karaguni, I.M., Li, X., Flatau, G., Muller, O., Zimber, A., Gespach, C., and Mareel, M.M. (2002). Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways. Oncogene 21, 6740-6750.
15. Ellis, V., Pyke, C., Eriksen, J., Solberg, H., and Dano, K. (1992). The urokinase receptor: involvement in cell surface proteolysis and cancer invasion. Ann. N.Y. Acad. Sci. 667, 13-31.
16. Fibbi, G., Barletta, E., Dini, G., Del Rosso, A., Pucci, M., Cerletti, M., and Del Rosso, M. (2001). Cell invasion is affected by differential expression of the urokinase plasminogen activator/urokinase plasminogen activator receptor system in muscle satellite cells. Lab. Investig. 81, 27-39.
17. Ganesh, S., Sier, C.F., Heerding, M.M., Griffioen, G., Lamers, C.B., and Verspaget, H.W. (1994). Urokinase receptor and colorectal cancer survival. Lancet 344, 401-401.
18. Halvorsen, B., Staff, A.C., Ligaarden, S., Prydz, K., and Kolset, S.O. (2000). Lithocholic acid and sulphated lithocholic acid differs in the ability to promote matrix metalloproteinase secretion in the human colon cancer cell line Caco-2. Biochem. J. 349, 189-193.
19. Hao, X.P., Tomlinson, I.P., Ilyas, M., Palazzo, J.P., and Talbot, I.C. (1997). Reciprocity between membranous and nuclear expression of β-catenin in colorectal tumors. Virchows Arch. 431, 167-172.
20. Hiscox, S., and Jiang, W.G. (1999). Hepatocyte growth factor/scatter factor disrupts epithelial tumor cell-cell adhesion: involvement of beta-catenin. Anticancer Res. 19, 509-518.
21. Hoffman, A.F. (1989). Enterohepatic circulation of bile acids. In: Handbook of Physiology, Section on the Gastrointestinal System, ed. S.G. Schultz, Bethesda, MD: American Physiological Society, 567-596.
22. Jacoby, R.F., Marshall, D.J., Kailas, S., Schlack, S., Harms, B., and Love, R. (1995). Genetic instability associated with adenoma to carcinoma progression in hereditary nonpolyposis colon cancer. Gastroenterology 109, 73-82.
23. Kinzler, K.W., and Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell 87, 159-170.
24. Korpela, J.T., Adlercreutz, H., and Turunen, M.J. (1988). Fecal free and conjugated bile acids and neutral sterols in vegetarians, omnivores, and patients with colorectal cancer. Scand. J. Gastroenterol. 23, 277-283.
25. Mann, B., et al. (1999). Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Natl. Acad. Sci. USA 96, 1603-1608.
26. Milovic, V., Teller, I.C., Faust, D., Caspary, W.F., and Stein, J. (2002). Effects of deoxycholate on human colon cancer cells: apoptosis or proliferation. Eur. J. Clin. Investig. 32, 29-34.
27. Morin, P.J. (1999). Beta-catenin signaling and cancer. Bioessays 21, 1021-1030.
28. Moseley, R.H. (1999). Bile secretion. In: Textbook of Gastroenterology, 3rd ed. Chapter 17, ed. T. Yamada, Philadelphia: Lippincott Williams & Wilkins, 380-403.
29. Pai, R., Nakamura, T., Moon, W.S., and Tarnawski, A.S. (2003). Prostaglandins promote colon cancer cell invasion: signaling by cross-talk between two growth factor receptors. FASEB J. 77, 1640-1647.
30. 2 transactivates EGF receptor and triggers mitogenic signaling in gastric mucosa and colon cancer cells. A novel mechanism for colon cancer growth and gastrointestinal hypertrophy. Nat. Med. 8, 289-293.
31. Peifer, M. (1997). beta-Catenin as oncogene: the smoking gun. Science 275, 1752-1753.
32. Peiffer, L.P., Peters, D.J., and McGarrity, T.J. (1997). Differential effects of deoxycholic acid on proliferation of neoplastic and differentiated colonocytes in vitro. Dig. Dis. Sci. 42, 2234-2240.
33. Poch, B., Gansauge, F., Schwarz, A., Seufferlein, T., Schnelldorfer, T., Ramadani, M., Beger, H.G., and Gansauge, S. (2001). Epidermal growth factor induces cyclin D1 in human pancreatic carcinoma: evidence for a cyclin D1-dependent cell cycle progression. Pancreas 23, 280-287.
34. Polakis, P. (1997). The adenomatous polyposis coli (APC) tumor suppressor. Biochim. Biophys. Acta 1332, F127-F147.
35. Polakis, P. (2000). Wnt signaling and cancer. Genes Dev. 14, 1837-1851.
36. Pyke, C., Kristensen, P., Ralfkiaer, E., Grondahl-Hansen, J., Eriksen, J., Blasi, F., and Dano, K. (1991). Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinoma. Am. J. Pathol. 138, 1059-1067.
37. Qiao, L., et al. (2001). Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. Mol. Biol. Cell 12, 2629-2645.
38. Reddy, B.S. (1992). Dietary fat and colon cancer: animal model studies. Lipids 27, 807-813.
39. Rogers, A.E., Zeisel, S.H., and Groopman, J. (1993). Diet and carcinogenesis. Carcinogenesis 14, 2205-2217.
40. 2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 276, 18075-18081.
41. Shtutman, M., Zhurinsky, J., Simcha, I., Albanese, C., D'Amico, M., Pestell, R., and Ben-Ze'ev, A. (1999). The cyclin D1 gene is a target of the β-catenin/Lef-1 pathway. Proc. Natl. Acad. Sci. USA 96, 5522-5527.
42. Stadler, J., Yeung, K.S., Furrer, R., Marcon, N., Himal, H.S., and Bruce, W.R. (1988). Proliferative activity of rectal mucosa and soluble fecal bile acids in patients with normal colons and in patients with colonic polyps or cancer. Cancer Lett. 38, 315-320.
43. Tabengwa, E.M., Grenett, H.E., Benza, R.L., Abou-Agag, L.H., Tresnak, J.K., Wheeler, C.G., and Booyse, F.M (2001). Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells. Alcohol Clin. Exp. Res. 25, 163-170.
44. Yoon, J.H., Higuchi, H., Werneburg, N.W., Kaufmann, S.H., and Gores, G.J. (2002). Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line. Gastroenterology 122, 985-993.
45. Yu, W., Kim, J., and Ossowski, L. (1997). Reduction in surface urokinase receptor forces malignant cells into a protracted state of dormancy. J. Cell Biol. 137, 767-777.